साई व्हाइब्रियोनिक्स पत्रिका

A 51-year-old female was suffering from severe pain and mild swelling in her knees for just over a year since Nov 2021. Pain significantly hindered her ability to walk normally, causing an unsteady gait. Walking exacerbated the pain and  caused cramps in her legs. She was unable to sit on the floor, previously an effortless and regular activity. She relied on over-the-counter pain relief gel and took rest whenever necessary. On 13 May 2022, she consulted an orthopaedic doctor who conducted an X-ray and MRI scan, diagnosing her condition as Grade 3 osteoarthritis. She was prescribed ultrasound physiotherapy (UST), tablets and a gel. However, due to increased pain, UST was stopped after a week and tablets in another month due to lack of relief. She continued with the prescribed gel for seven months until she discovered vibrionics.

On 20 Jan 2023, she was given:

CC3.7 Circulation + CC12.1 Adult tonic + CC18.5 Neuralgia + CC20.3 Arthritis + CC20.4 Muscles & Supportive tissue + CC20.6 Osteoporosis…TDS

On 20 Feb, she reported 90% relief from pain, with swelling completely gone, allowing her to walk normally without cramps. By 30 Mar, pain vanished and she could comfortably sit or sleep on the floor. The dosage was reduced to BD and slowly tapered off until remedy stopped on 25 July 2023.

As of Oct 2024, she continues to be comfortable and attend to her daily activities.